> If the US government is happy to hand out billions in funding and then pay a high price for the doses, why would a private company not take advantage of this?
The US government paid Moderna $1B to fund the development and $1.5B for 100 million doses. They are paying Pfizer $1.9B for 100 million doses of their vaccine. I don't consider $25/dose (maximum) or $19/dose to be "a high price".
It is a high price when you consider low income countries. For example, in Sudan the average monthly income is about ~$49. That's less than the cost of a 2 dose regime of this vaccine. That's a $2 billion price tag to vaccine all 40+ million Sudanese. Africa has 1.2 billion people. It is going to be extraordinarily expensive and difficult to eradicate COVID globally, so we are going to need cheaper vaccines to help us do that.
There is no reason other than political will stopping the WHO and developed nations from subsidizing the purchase of vaccines for places like Africa. In fact, I don't think there is any vaccine that a country like Sudan could afford to administer without such subsidies. Additionally, I suspect the cost of distributing and administering the SARS-CoV-2 vaccine in those areas is going to dwarf the raw cost of the doses anyway, considering the temperature sensitivities of the front runner candidates.
That said, the person I was replying to was claiming the price was too high for some developed nations.
The US government paid Moderna $1B to fund the development and $1.5B for 100 million doses. They are paying Pfizer $1.9B for 100 million doses of their vaccine. I don't consider $25/dose (maximum) or $19/dose to be "a high price".
https://www.nytimes.com/interactive/2020/science/coronavirus...